Snowden Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $445K | Buy |
11,464
+5,895
| +106% | +$229K | 0.01% | 818 |
|
|
2025
Q1 | $218K | Sell |
5,569
-1,461
| -21% | -$57.2K | 0.01% | 1125 |
|
|
2024
Q4 | $247K | Sell |
7,030
-20,341
| -74% | -$714K | 0.01% | 1077 |
|
|
2024
Q3 | $1.13M | Buy |
27,371
+2,429
| +10% | +$100K | 0.03% | 484 |
|
|
2024
Q2 | $971K | Sell |
24,942
-4,081
| -14% | -$159K | 0.03% | 513 |
|
|
2024
Q1 | $1.26M | Buy |
29,023
+4,472
| +18% | +$194K | 0.04% | 442 |
|
|
2023
Q4 | $910K | Sell |
24,551
-2,691
| -10% | -$99.7K | 0.03% | 469 |
|
|
2023
Q3 | $988K | Sell |
27,242
-1,194
| -4% | -$43.3K | 0.04% | 423 |
|
|
2023
Q2 | $1.01M | Buy |
28,436
+5,146
| +22% | +$183K | 0.04% | 456 |
|
|
2023
Q1 | $829K | Buy |
23,290
+779
| +3% | +$27.7K | 0.03% | 512 |
|
|
2022
Q4 | $791K | Buy |
22,511
+2,444
| +12% | +$85.9K | 0.03% | 512 |
|
|
2022
Q3 | $590K | Sell |
20,067
-7,693
| -28% | -$226K | 0.03% | 586 |
|
|
2022
Q2 | $1.51M | Buy |
27,760
+14,494
| +109% | +$788K | 0.07% | 316 |
|
|
2022
Q1 | $722K | Buy |
13,266
+11,493
| +648% | +$626K | 0.03% | 522 |
|
|
2021
Q4 | $97K | Buy |
+1,773
| New | +$97K | 0.01% | 848 |
|
|
2021
Q1 | – | Sell |
-42,274
| Closed | -$1.94M | – | 801 |
|
|
2020
Q4 | $1.94M | Buy |
42,274
+2,256
| +6% | +$104K | 0.13% | 216 |
|
|
2020
Q3 | $1.88M | Buy |
40,018
+2,426
| +6% | +$114K | 0.15% | 190 |
|
|
2020
Q2 | $1.92M | Buy |
37,592
+2,049
| +6% | +$104K | 0.16% | 184 |
|
|
2020
Q1 | $1.68M | Buy |
35,543
+3,098
| +10% | +$147K | 0.18% | 169 |
|
|
2019
Q4 | $1.91M | Buy |
32,445
+675
| +2% | +$39.6K | 0.17% | 180 |
|
|
2019
Q3 | $1.69M | Buy |
31,770
+1,096
| +4% | +$58.5K | 0.17% | 179 |
|
|
2019
Q2 | $1.53M | Buy |
30,674
+3,371
| +12% | +$169K | 0.16% | 196 |
|
|
2019
Q1 | $1.43M | Buy |
+27,303
| New | +$1.43M | 0.16% | 200 |
|